Last checked at 13 Mar 2024 14:26
13 March 2024
HeiQ PLC
("HeiQ" or "the Company")
Result of General Meeting, Issue of Equity & Total Voting Rights
The Company announces that all Resolutions were duly passed by Shareholders at the General Meeting held today in connection with the recently announced Fundraising.
The results of the voting were as follows:
Resolution | In favour | Against | Withheld |
1. To sub-divide the ordinary shares | 43,627,201 | 3,213,056 | 56,011 |
2. to amend the company's articles | 43,627, 704 | 3,212,556 | 56,011 |
3. to authorise the directors to allot ordinary shares | 43,634,062 | 3,206,201 | 56,011 |
4. to authorise the directors to disaaply pre-emption rights | 43,627,710 | 3,212,556 | 56,011 |
Copies of the resolutions required to be made available for inspection in accordance with LR 9.6.2 have been submitted today to the Financial Conduct Authority and will shortly be available for inspection on the National Storage Mechanism website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
Accordingly, the Company announces the issuance of 28,000,000 New Ordinary Shares and applications have been made for the 28,000,000 New Ordinary Shares to be admitted to the standard segment of the Official List and admitted to trading on the London Stock Exchange ("Admission"), comprising (i) 7,866,709 Placing Shares; (ii) 862,069 Retail Shares and (iii) 19,271,222 Convertible Loan Note Shares. Admission is expected to occur tomorrow, 14 March 2024.
Following the issue and allotment of the New Ordinary Shares the Company has 168,537,907 Ordinary Shares in issue. The Company holds no Ordinary Shares in treasury, and therefore the total number of voting rights in the Company is 168,537,907. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Furthermore, the Capital Reorganisation which comprises a subdivision of each Existing Ordinary Share of 30p into one New Ordinary Share of 5 pence and one Deferred Share of 25 pence, will become effective tomorrow. This is a technical change only and does not affect the rights of any holder of Existing Ordinary Shares.
Unless otherwise defined, capitalised terms shall have the same meaning as those set out in its announcement regarding the Fundraising dated 15 February 2024.
For further information, please contact:
HeiQ Plc Carlo Centonze (CEO) | +41 56 250 68 50 |
Cavendish Capital Markets Limited (Broker) Stephen Keys / Callum Davidson | +44 (0) 207 397 8900 |
SEC Newgate (Media Enquiries) Elisabeth Cowell / Molly Gretton / Tom Carnegie | +44 (0) 20 3757 6882 HeiQ@secnewgate.co.uk |
Further information on the Company can be found on its website at: https://www.heiq.com/investor-relations/
This announcement should be read in its entirety. In particular, the information in the "Important Notices" section of the announcement should be read and understood.
About HeiQ
HeiQ is a Swiss-based international company that innovates pioneering and differentiating materials in partnership with established global brands. We bridge the academic and commercial worlds to conceive performance-enhancing materials and technologies, working with aligned brands to research, manufacture and bring products to market, aiming for lab to consumer in months. Our goal is to improve the lives of billions by innovating the materials that go into everyday products, making them more hygienic, comfortable, protective, and sustainable.
Our strong IP portfolio positions us as an innovation leader for niche, premium and high-margin products in the textile chemicals, man-made fibers, paints and coatings, antimicrobial plastics, probiotics and household cleaner markets. We have also expanded into healthcare facilities, probiotic cleaning, and hygiene coatings markets to help make hospitals and healthcare environments more hygienic.
We have developed over 200 technologies in partnership with 300 major brands. With a substantial research and development pipeline, including key technology development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ GrapheneX, and HeiQ Synbio, HeiQ aims to deliver shareholder value through sales growth and entry into new lucrative markets through disruptive innovation and M&A.
We have built a strong reputation for ESG & sustainable innovation, having won multiple awards including the Swiss Technology Award twice and the Swiss Environmental Award. Under experienced leadership, we are committed to driving our profit in close connection with people and the planet. For more information, please visit www.heiq.com.